Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700058270

Next Previous
X
Search
Trial Profile

Clinical Trials Insight: 700058270

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 09 Apr 2020

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs DRL 17822 (Primary)
  • Indications Atherosclerosis; Chronic obstructive pulmonary disease; Dyslipidaemias
  • Focus Adverse reactions
  • Sponsors Dr Reddys Laboratories

    • Most Recent Events

    • 06 Apr 2020 Results from four phase 1 studies: study 1: first-in-human single dose phase, study 2: single dose food interaction study, study 3: two-week once daily multiple dose study and study 4: (part A and B) was a single dose food and formulation interaction study on the population pharmacokinetics of DRL-17822 in healthy male volunteers were published in the British Journal of Clinical Pharmacology
    • 29 Jun 2010 New trial record.
    • 29 Jun 2010 Results were reported at the 70th Annual Scientific Sessions of the American Diabetes Association.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top